GO
Loading...

Enter multiple symbols separated by commas

Search results for "WPI"

REFINE RESULTS

SEARCH RESULTS

About 25 results. Sort By: Date | Relevance
RPT-Mylan independence from Teva's embrace comes with a price

Mylan, whose shares fell 14.5 percent, said it would continue its own unsolicited pursuit of Irish drugmaker Perrigo Co, a maker of over-the-counter consumer and nutritional products and generic topical medicines. Perrigo is one of the few remaining assets out there, "said Morningstar analyst Michael Waterhouse. Other industry analysts expect Mylan will...
Source: Reuters | By: Bill Berkrot
UPDATE 1-Allergan CEO, fresh off one deal, sets sights on others

NEW YORK, July 27- Allergan plc CEO Brent Saunders is ready to put the $36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger. As head of Actavis, he then sealed a $66 billion purchase of Botox-maker Allergan, beating out rival suitor Valeant...
Source: Reuters | By: Caroline Humer
US STOCKS-Wall St drops as China stock slump stokes growth fears

*Oil prices, commodities lower following China equity selloff. *Teva, Allergan jump after $40.5 bln deal. U.S.-listed shares of Chinese companies slid, including Alibaba and Baozun.
Source: Reuters | By: Noel Randewich
Teva and Restaurant Brands are big market movers

NEW YORK- Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Teva Pharmaceuticals Industries Ltd., up $10.15 to $72. Restaurant Brands International Inc., up $1.41 to $41.50.
Source: The Associated Press
Analysts expect more tie-ups in generic drug business

The Dutch drugmaker Mylan, which had resisted Teva's advances for three months, is pressing ahead with its offer for Irish drug and ingredients maker Perrigo. Perrigo has turned down Mylan's offer. If they can't work it out, Perrigo might find other suitors as the competitive generic drug industry keeps consolidating.
Source: The Associated Press
US STOCKS-Wall St sinks as tumbling China equities stoke growth worry

*Oil prices, commodities lower following China equity crash. *Teva, Allergan jump after $40.5 bln deal. The NYSE showed 459 stocks at 52- week lows, the most in a day since Oct. 15.
Source: Reuters | By: Noel Randewich
US STOCKS-Wall St slumps after China stocks stumble

*Teva, Allergan jump after $40.5 bln deal. July 27- Wall Street began the week in the red on Monday and fell sharply on concerns about China's slowing growth in the wake of the biggest drop in Shanghai shares in eight years. China's top securities regulator, China Securities Regulatory Commission, said on Monday that Beijing would continue to buy shares to...
Source: Reuters | By: Tanya Agrawal
Allergan CEO, fresh off one deal, sets sights on others

NEW YORK, July 27- Allergan CEO Brent Saunders said on Monday the company will use the $36 billion it nets from the sale of its generics business to Teva for more deals, including large, "transformational" merger opportunities. Saunders, who led the $66 billion combination of Actavis and Allergan that closed only a few months ago, told investors that it would use the...
Source: Reuters
US STOCKS-Wall St dips after China stocks tumble

*Teva, Allergan jump after $40.5 bln deal. July 27- Wall Street began the week in the red on Monday and fell sharply on concerns about China's slowing growth in the wake of the biggest drop in Shanghai shares in eight years. Chinese ADRs including Alibaba, Baozun, Sohu.com and JD.com slid.
Source: Reuters | By: Tanya Agrawal
China stocks volatile after big fall, Hong Kong rises

NEW YORK- The worst drop in China's stock market in eight years helped drag down other markets around the world Monday. Faced with a drop in stock prices in Asia, Europe and the U.S., investors moved into traditional safe havens. "There remain very few buyers out there and there are some growing concerns that we're looking at a slowdown in global economic growth," said...
Source: The Associated Press